Literature DB >> 17991289

Increased expression of Toll-like receptor (TLR) 2 and TLR4 in the colonic mucosa of children with inflammatory bowel disease.

B Szebeni1, G Veres, A Dezsõfi, K Rusai, A Vannay, M Mraz, E Majorova, A Arató.   

Abstract

Inflammatory bowel disease (IBD) may result from exaggerated stimulation of the mucosal immune system by luminal bacterial flora. Bacterial products are recognized by pattern recognition receptors such as Toll-like receptors (TLRs), which are key regulators of the innate immune system. Therefore, the expression of TLR2, TLR3 and TLR4 in colonic biopsy samples taken from children with active IBD were studied and compared to controls. Colonic biopsy samples were collected from macroscopically inflamed and non-inflamed regions of the mucosa of 12 children with freshly diagnosed IBD (fdIBD) and 23 children with relapsed IBD (rIBD). Specimens were also obtained from eight controls. TLR2, TLR3 and TLR4 mRNA expression and protein levels were determined by real-time reverse transcription polymerase chain reaction (RT-PCR) and Western blot. We found higher TLR2 and TLR4 mRNA and protein levels in the inflamed colonic mucosa of children with fdIBD and rIBD compared to controls. In the non-inflamed colonic mucosa of children with fdIBD and rIBD, TLR2 and TLR4 mRNA and protein levels were similar to controls. TLR2 and TLR4 mRNA and protein levels also did not differ between children with fdIBD or rIBD in either inflamed or non-inflamed colonic mucosa. TLR3 mRNA expression and protein levels were similar in all groups studied. Our results of increased levels of TLR2 and TLR4 in the inflamed colonic mucosa of children with IBD confirm the hypothesis that innate immunity has an important role in the pathogenesis of this disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17991289      PMCID: PMC2276924          DOI: 10.1111/j.1365-2249.2007.03531.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  50 in total

Review 1.  Toll-like receptors and innate immunity.

Authors:  R Medzhitov
Journal:  Nat Rev Immunol       Date:  2001-11       Impact factor: 53.106

Review 2.  Inflammatory bowel disease in early childhood and adolescence: special considerations.

Authors:  Petar Mamula; Jonathan E Markowitz; Robert N Baldassano
Journal:  Gastroenterol Clin North Am       Date:  2003-09       Impact factor: 3.806

3.  Characteristics of intestinal dendritic cells in inflammatory bowel diseases.

Authors:  Ailsa L Hart; Hafid Omar Al-Hassi; Rachael J Rigby; Sally J Bell; Anton V Emmanuel; Stella C Knight; Michael A Kamm; Andrew J Stagg
Journal:  Gastroenterology       Date:  2005-07       Impact factor: 22.682

4.  Challenges in pediatric inflammatory bowel disease.

Authors:  Athos Bousvaros; Francisco Sylvester; Subra Kugathasan; Eva Szigethy; Claudio Fiocchi; Richard Colletti; Anthony Otley; Devendra Amre; George Ferry; Steven J Czinn; Judy B Splawski; Maria Oliva-Hemker; Jeffrey S Hyams; William A Faubion; Barbara S Kirschner; Marla C Dubinsky
Journal:  Inflamm Bowel Dis       Date:  2006-09       Impact factor: 5.325

5.  The role of CD40 in ulcerative colitis: histochemical analysis and clinical correlation.

Authors:  Lino Polese; Imerio Angriman; Attilio Cecchetto; Lorenzo Norberto; Marco Scarpa; Cesare Ruffolo; Michela Barollo; Antonio Sommariva; Davide F D'Amico
Journal:  Eur J Gastroenterol Hepatol       Date:  2002-03       Impact factor: 2.566

6.  Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines.

Authors:  Kol A Zarember; Paul J Godowski
Journal:  J Immunol       Date:  2002-01-15       Impact factor: 5.422

7.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene.

Authors:  A Poltorak; X He; I Smirnova; M Y Liu; C Van Huffel; X Du; D Birdwell; E Alejos; M Silva; C Galanos; M Freudenberg; P Ricciardi-Castagnoli; B Layton; B Beutler
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

8.  Bacterial peptidoglycan induces CD14-dependent activation of transcription factors CREB/ATF and AP-1.

Authors:  D Gupta; Q Wang; C Vinson; R Dziarski
Journal:  J Biol Chem       Date:  1999-05-14       Impact factor: 5.157

9.  Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)

Authors:  R Duchmann; I Kaiser; E Hermann; W Mayet; K Ewe; K H Meyer zum Büschenfelde
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

Review 10.  Toll-like receptors.

Authors:  Kiyoshi Takeda; Tsuneyasu Kaisho; Shizuo Akira
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

View more
  67 in total

Review 1.  Intestinal epithelial cells in inflammatory bowel diseases.

Authors:  Giulia Roda; Alessandro Sartini; Elisabetta Zambon; Andrea Calafiore; Margherita Marocchi; Alessandra Caponi; Andrea Belluzzi; Enrico Roda
Journal:  World J Gastroenterol       Date:  2010-09-14       Impact factor: 5.742

Review 2.  Toll-like receptors in inflammatory bowel disease-stepping into uncharted territory.

Authors:  Avi Levin; Oren Shibolet
Journal:  World J Gastroenterol       Date:  2008-09-07       Impact factor: 5.742

Review 3.  Domino effect of hypomagnesemia on the innate immunity of Crohn's disease patients.

Authors:  Saleh A Naser; Almatmed Abdelsalam; Saisathya Thanigachalam; Abed S Naser; Karel Alcedo
Journal:  World J Diabetes       Date:  2014-08-15

4.  Prescription Opioids induce Gut Dysbiosis and Exacerbate Colitis in a Murine Model of Inflammatory Bowel Disease.

Authors:  Umakant Sharma; Rohini Khatri Olson; Federico Nicolas Erhart; Li Zhang; Jingjing Meng; Bradley Segura; Santanu Banerjee; Madhulika Sharma; Ashok Kumar Saluja; Sundaram Ramakrishnan; Maria T Abreu; Sabita Roy
Journal:  J Crohns Colitis       Date:  2020-07-09       Impact factor: 9.071

Review 5.  Host genetic susceptibility, dysbiosis, and viral triggers in inflammatory bowel disease.

Authors:  Lulu Sun; Gerardo M Nava; Thaddeus S Stappenbeck
Journal:  Curr Opin Gastroenterol       Date:  2011-07       Impact factor: 3.287

6.  Effects of alanyl-glutamine dipeptide on the expression of colon-inflammatory mediators during the recovery phase of colitis induced by dextran sulfate sodium.

Authors:  Yu-Chen Hou; Chia-Chou Chu; Tsui-Ling Ko; Chiu-Li Yeh; Sung-Ling Yeh
Journal:  Eur J Nutr       Date:  2012-07-31       Impact factor: 5.614

Review 7.  Rheumatic manifestations of inflammatory bowel disease.

Authors:  Tatiana Sofía Rodríguez-Reyna; Cynthia Martínez-Reyes; Jesús Kazúo Yamamoto-Furusho
Journal:  World J Gastroenterol       Date:  2009-11-28       Impact factor: 5.742

8.  A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis.

Authors:  Ryan Ungaro; Masayuki Fukata; David Hsu; Yasmin Hernandez; Keith Breglio; Anli Chen; Ruliang Xu; John Sotolongo; Cecillia Espana; Julia Zaias; Greg Elson; Lloyd Mayer; Marie Kosco-Vilbois; Maria T Abreu
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-04-09       Impact factor: 4.052

9.  Toll-like receptor regulation of intestinal development and inflammation in the pathogenesis of necrotizing enterocolitis.

Authors:  Peng Lu; Chhinder P Sodhi; David J Hackam
Journal:  Pathophysiology       Date:  2013-12-22

10.  Understanding diversity of human innate immunity receptors: analysis of surface features of leucine-rich repeat domains in NLRs and TLRs.

Authors:  Andrei Y Istomin; Adam Godzik
Journal:  BMC Immunol       Date:  2009-09-03       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.